Model-Based Simulation and Prediction of an Antiviral Strategy against Influenza A Infection

Biphasic RLR-IFN-  Response Controls the Balance between Antiviral Immunity and Cell Damage

(2013) S.-Y. Hwang et al.   JOURNAL OF IMMUNOLOGY

Influenza virus and cell signaling pathways

(2013) Pratibha Gaur et al.   MEDICAL SCIENCE MONITOR

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

(2012) A. C. Hurt et al.   JOURNAL OF INFECTIOUS DISEASES

Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011

(2012) Ji-Rong Yang et al.   JOURNAL OF MEDICAL VIROLOGY

Intrinsic antiviral immunity

(2012) Nan Yan et al.   NATURE IMMUNOLOGY

A review of influenza haemagglutinin receptor binding as it relates to pandemic properties

(2012) Sam Wilks et al.   VACCINE

Stochastic Expression of the Interferon-β Gene

(2012) Mingwei Zhao et al.   PLOS BIOLOGY

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010

(2011) Adam Meijer et al.   ANTIVIRAL RESEARCH

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

(2011) Catherine AA Beauchemin et al.   BMC PUBLIC HEALTH

Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor

(2011) Miguel A Mata et al.   Nature Chemical Biology

5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity

(2011) Sun-Young Hwang et al.   NUCLEIC ACIDS RESEARCH

Antiviral Strategies for Pandemic and Seasonal Influenza

(2011) Maria Hedlund et al.   Viruses-Basel

Influenza A virus infection kinetics: quantitative data and models

(2011) Amber M. Smith et al.   Wiley Interdisciplinary Reviews-Systems Biology and Medicine

Immune Response Modeling of Interferon β-Pretreated Influenza Virus-Infected Human Dendritic Cells

(2010) Liang Qiao et al.   BIOPHYSICAL JOURNAL

Antivirals compounds in the pipeline to tackle H1N1 Influenza infection

(2010) J.H. Beigel   DRUGS OF THE FUTURE

New Insights into the Role of RNase L in Innate Immunity

(2010) Arindam Chakrabarti et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Higher Level of Replication Efficiency of 2009 (H1N1) Pandemic Influenza Virus than Those of Seasonal and Avian Strains: Kinetics from Epithelial Cell Culture and Computational Modeling

(2010) H. Mitchell et al.   JOURNAL OF VIROLOGY

Antiviral Strategies: The Present and Beyond

(2010) J. Burke et al.   Current Molecular Pharmacology

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

(2009) J. T. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice

(2009) D. F. Smee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Influenza Virus Enigma

(2009) Rachelle Salomon et al.   CELL

Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

(2009) Nila J. Dharan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production—Flow cytometry and mathematical modeling

(2009) J. Schulze-Horsel et al.   VACCINE

Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice

(2008) N. A. Ilyushina et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Virus Infection Induces NF-κB-Dependent Interchromosomal Associations Mediating Monoallelic IFN-β Gene Expression

(2008) Effie Apostolou et al.   CELL

Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?

(2008) Frederick Hayden   CLINICAL INFECTIOUS DISEASES